Skip to main content
SpringerLink
Log in

Komorbidität von Depression und Herzinsuffizienz

Zweijährige Therapie mit Escitalopram bleibt ohne durchschlagenden Effekt

  • journal club
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  • Angermann CE, Gelbrich G, Störk S et al. Effect of escitalo-pram on all-cause mortality and hospitalization in patients with heart failure and depression. The MOOD-HF randomized clinical trial. JAMA 2016; 315: 2683 – 93

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Psychiatrische Klinik, Universitätsklinikum Erlangen, Erlangen, Deutschland

    Nicola Tran-Vinh

Authors
  1. Nicola Tran-Vinh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicola Tran-Vinh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tran-Vinh, N. Zweijährige Therapie mit Escitalopram bleibt ohne durchschlagenden Effekt. InFo Neurologie 19, 27–28 (2017). https://doi.org/10.1007/s15005-017-2105-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-017-2105-5

Search

Navigation